1.A randomized controlled study of treating chronic rhinosinusitis with macrolides.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(17):1289-1291
OBJECTIVE:
Invastigation of macrolides in the treatment of drug effects in chronic rhinosinusit.
METHOD:
The 165 patients with chronic rhinosinusit were randomly divided into 80 cases of macrolides drug group and 85 cases of cephalosporins group, and therapeutic effect was observed. The therapeutic effect of macrolides was also observed in refractory chronic rhinosinusit.
RESULT:
Comparing macrolides group and cephalosporins group,there is not statistically significant (P > 0.05). Treatment with macrolides cefixime tablet ineffective treatment of patients for 3 months, compared before and after treatment was statistically significant (P < 0.01). Treatment with cefixime tablet macrolides ineffective treatment of patients for 3 months, compared before and after treatment was not statistically significant (P > 0.05).
CONCLUSION
Long-term low-dose applications of macrolides have a good effect in patients with chronic rhinosinusit, particularly for refractory chronic rhinosinusit have a significant effect.
Anti-Bacterial Agents
;
therapeutic use
;
Cephalosporins
;
therapeutic use
;
Chronic Disease
;
Humans
;
Macrolides
;
therapeutic use
;
Rhinitis
;
drug therapy
;
Sinusitis
;
drug therapy
;
Treatment Outcome
3.Quality assurance of stereotactic radiotherapy in head and neck cancer
Chinese Medical Equipment Journal 2004;0(07):-
Objective To introduce the methods for quality assurance of stereotactic radiotherapy in head and neck cancers.Methods Firstly,thirty cases were randomly selected.Secondly,patients were set up with Topsland fixtures,and their heads & necks were fixed with plastic masks,on which windows were open and the signs of reposition were marked.Thirdly,the treatment plan was designed by GE-helical CT-scan and Topsland plan system.Finally,after certification eligibility,the treatment plan was performed to record the parameters of anterior-posterior and analysis errors of setting up.Results: The testing results revealed that the position error was no more than 2mm.Conclusion: QA is a very important measure to guarantee the precision of stereoscopic directional radiotherapy.Only when the QA measure has been strictly carried out,the precise and satisfactory effect can be obtained.
4.The relationship between accompanying infection and immunologic function changes in type 2 diabetes melli-tus patients
Bing YU ; Ping YU ; Li LI ; Qiang CHEN ; Chunli WU
Chinese Journal of Primary Medicine and Pharmacy 2016;23(5):690-694
Objective To investigate the relationship between accompanying infection and the change of immunologic function in type 2 diabetes mellitus ( T2DM) patients.Methods One hundred and fifteen T2DM patients with infection and 95 T2DM patients with no infection were selected,and 102 subjects with no history of dia-betes were selected as no diabetetes with infection group.The venous blood of all groups were sampled after an over-night fast of 12h.Glycosylated hemoglobin a1c(HbA1c) level was tested by glycosylated hemoglobin automatic analy-zer.The levels of T cell subsets including CD3 ,CD4 ,CD8 ,NK cell and B cell ratio were tested by flow cytometry,Ig and complement level was tested by immune nephelometry.Results The level of body mass indices(BMI) in T2DM patients with infection group[(27.39 ±9.18) kg/m2 ] and with no infection group[(26.15 ±7.39) kg/m2 ] were higher than no diabetes with infection group (24.21 ±5.37)kg/m2 (t =2.548,4.702,all P <0.05).The levels of IgG,IgA,IgM,C3 ,C4 in T2DM with infection group were (11.83 ±3.92)mg/mL,(3.02 ±0.96)mg/mL,(3.38 ± 0.82)mg/mL,(1.70 ±0.38)mg/mL,(0.52 ±0.18)mg/mL,which in T2DM with non infection group were (12.46 ± 2.47)mg/mL,(2.63 ±1.37)mg/mL,(2.91 ±1.79)mg/mL,(1.58 ±0.43)mg/mL,(0.46 ±0.31)mg/mL,which in no diabetetes with infection group were (13.26 ±3.74)mg/mL,(2.06 ±1.86)mg/mL,(2.49 ±1.01)mg/mL, (1.19 ±0.82)mg/mL,(0.30 ±0.05)mg/mL.In T2DM with non infection group and T2DM with infection group, humoral immunity index including the level of IgG was lower and IgA,IgM,C3 ,C4 levels were higher than no dia-betetes with infection group,the differences were statistically significant(t =7.052,23.059,12.617,18.326,8.730, all P <0.05).The levels of CD4 ,CD8 ,NK,CD4 /CD8 ,CD3 were (37.68 ±8.39)%,(31.58 ±6.98)%,(10.76 ± 6.49)%,(1.19 ±0.75),(62.83 ±5.28)% in T2DM with infection group,which in T2DM with non infection group were (39.23 ±10.28)%,(27.61 ±5.65)%,(14.89 ±7.12)%,(1.39 ±1.01),(64.19 ±6.46)%,which in no diabetes with infection group were (42.91 ±5.67)%,(25.17 ±7.25)%,(16.39 ±6.24)%,(1.86 ±0.82), (73.65 ±9.10)%.Cellular immunity index containing CD4 ,CD8 ,NK,CD4 /CD8 ,CD3 levels decreased more signifi-cantly than no diabetic group,T2DMI group compared with T2DM group,the levels of IgG,CD4 ,CD8 ,NK,B cell ratio, CD4 /CD8 ,CD3 decreased obviously,while the levels of IgA,IgM,C3 declined greatly,there were significant differences (t =11.038,8.237,18.549,25.871,2.436,all P <0.05).Conclusion Patients with T2DM have humoral and cellular immunity abnormalities,T2DM patients with infection is closely related with the imbalance of immunologic function.
5.Expressions of human fibrinogen-like protein 2 in peripheral and cerebrospinal fluid white blood cells in patients with cryptococcal meningitis
Yanjun LI ; Yanhong YU ; Jizhou WU
Chinese Journal of Infectious Diseases 2013;(1):33-36
Objective The purpose of this study was to explore the expression of human fibrinogen-like protein 2 (hFgl2) in patients with cryptococcal meningitis (CM).Methods The expression of hFgl2 in the peripheral blood leukocytes from 20 CM cases and 20 healthy individuals,and the expression of hFgl2 in cerebrospinal fluid (CSF) leukocytes in 11 pairs of CM patients and matched controls was detected using immunohistochemical methods.Medical image analysis system (MIAS) was used to analyze the expression of hFgl2 gray values,which were negatively correlated to the expression of hFgl2 protein in both peripheral blood and CSF.Results The average gray values for hFgl2 protein in peripheral monocytes of CM patients and healthy controls were 114.49± 11.82 and 137.56± 10.64,respectively,and those in peripheral neutrophils were 111.71 ± 8.62 and 143.56±12.57,respectively.Compared with the healthy control group,expressions of hFgl2 in peripheral blood monocytes and neutrophils were both significantly increased in CM patients (t =21.21,t=27.19; P<0.01).The average gray values for hFgl2 protein in CSF monocytes from CM patients and negative controls were 115.44±8.67 and 149.25±8.57,respectively,and those in CSFneutrophils were 111.71±8.62 and 143.56 ± 12.57,respectively.The expressions of hFgl2 in CSFmonocytes and neutrophils were significantly increased in CM patients (t =29.95,t=28.87; P<0.01),while the expression intensity of hFgl2 was similar when peripheral blood monocytes and neutrophils compared with their CSF counterparts (t=0.924,t=0.607; both P>0.05).Conclusions hFgl2 can be expressed in both peripheral and CSF monocytes and neutrophils in CM patients.
6.Medical nutrition therapy by evidence-based clinical pathway to improve outcome of gluten enteropathy: a case report
Rongrong LI ; Kang YU ; Dong WU
Chinese Journal of Clinical Nutrition 2013;21(6):373-377
Celiac disease (CD) is a chronic autoimmune gastrointestinal disorder induced by ingestion of gluten-containing foods.In the past CD was thought prevalent only in Western countries,whereas it has been found common throughout the world and increasing numbers of Chinese patients has been reported recently.However,there are still many deficiencies in management of patients with CD in China and either the diagnosis or the treatment of CD is lacking evidence-based clinical pathway.We report a case of a young woman with CD presenting with chronic diarrhea,abdominal distention,and weight loss,whose outcome was improved by following evidence-based guidelines of medical nutrition therapy.Diagnosis and treatment of the patient was analyzed with review of foreign and domestic literature to provide readers reference of the standardized nutritional intervention of CD.
7.Clinic research of rb-bFGF combined with boric acid solution in treatment of recurrent vulval ulcer
Hongyi DENG ; Xiaoling WU ; Yu LI
Chinese Journal of Primary Medicine and Pharmacy 2008;15(9):1481-1482
Objective To explore the effect of recombinant bovine basic fibroblast growth factor(rb-bFGF)combined with boric acid solution on vulval ulcer.Methods 64 patients with vulval ulcer were divided into two groupa randomly.33 patients( group A) with vulval ulcer was treated with rb-bFGF and boric acid solution locally,while the others (group B) accepted ultra-red rays.Before the different treatment above,metronidazole or clotrimasole was put into the vaginae of all the patients,which were given relative medicine according to etiopathogenesis.The two groups were treated continually for two weeks and then were examined.Results The effective rate in group A was significantly higher than that in group B,which was the same result as the ulcer heating time between two groups.Conclusion rb-bGFG combined with boric acid solution is an effective remedy for the treatment of vulval ulcer.
8.pMHC/scFv fusion protein mediates killing of tumor cells by viral specific cytotoxic T cells
Jianan LI ; Qian YU ; Xiongwen WU
Chinese Journal of Microbiology and Immunology 2011;31(2):162-167
Objective To study whether the HBC-A2/scFv fusion protein mediates killing of tumor cells by viral specific cytotoxic T cells. Methods The fusion protein was attached to the CD71-expressing, HLA class Ⅰ negative tumor cells. And then, cytolysis by viral peptide-specific CTLs which were generated by co-culture of peripheral blood lymphocytes from HLA-A2 positive donors with inactivated T2 cells pulsed with the viral peptide were tested by lactate dehydrogenase (LDH) releasing. Results The fusion protein can attach the active viral peptide/HLA-A2 complex to K562, HepG2 and U937 cells through binding of CD71 scFv to CD71 (37.30% ±8.25%, 27.20% ±3.88%, 21.80% ±6.49% ) and mediate cytotoxicity of viral peptide-specific CTLs against those cells in vitro ( K562: 42.08% ± 1.14% vs 8.07%± 1.39%; HepG2: 49.72% ± 1.59% vs 12.46% ± 1.26%; U937: 39.72% ± 3.26% vs 7.13% ±1.48% ). Conclusion This viral peptide/HLA-A2 complex targeted by CD71 scFv is able to redirect viral peptide-specific T-cell mediated immune responses against tumor cells.
9.Preliminary study of P3b potential in rats
Qian YU ; Xiaohong LI ; Zongyao WU
Chinese Journal of Physical Medicine and Rehabilitation 2001;23(2):86-89
Objective To discuss the characteristics and mechanism of P3b potentials in rats and establish the animal model of P3b.Methods P3b potentials and cell electric discharge in hippocampal CA1 region were recorded simultaneously inside cranio, septal and hippocampal CA1 region in rats.After septal lesions,the changes of P3b and cell electric discharge in hippocampal CA1 region were observed.Results P3b in hippocampal CA1 region was correlated well with its cell electric discharge. Following septal lesions,P3b and cell electric discharge decreased gradually and disapeared eventually. Conclusion Cell electric discharge in hippocampal CA1 region might be an important source of P3b.Normal structure and function of septal region were necessary to P3b's generation in hippocampal CA1 region. Additionally these suggested that cell electric discharge to target stimulation was important to P3b's generation.
10.Surgical treatment of Budd-Chiari syndrome caused by short segmental lesion of inferior vena cava and major hepatic veins
Xiaoqiang LI ; Chaowen YU ; Yunming WU
Chinese Journal of General Surgery 2001;16(5):280-282
Objective To evaluate the results of radical resection for the treatment of Budd-Chiari syndrome (BCS) caused by short segmental lesions in inferior vena cava (IVC), and major hepatic veins (MHV). Methods In this series, resection of IVC occlusive segment and orthotopic artificial vascular graft transplantation were performed in 42 patients. Resection of major hepatic vein, hepatic venous plasty and orthotopic transplantation with artificial vascular graft were performed in 10 patients. Resection of major hepatic vein, anastomosis between hepatic vein and right artrium in 3 cases. Percutaneous transhepatic angioplasty in 10 cases. Results One patient died of complication. 58 cases were followed up for an average of 30 months. 3 cases in interventional group suffered recurrence and one in surgical group had recurrence. Conclusions The treatment of BCS by resecting inflicted segment of IVC or hepatic veins and orthotopic artificial vascular graft transplantation effect a radical cure in most cases.